SHANGHAI--(BUSINESS WIRE)--ShangPharma Corporation (NYSE:SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its financial results for its third quarter ended September 30, 2010.
